Antinociceptive effect of the novel compound OT-7100 in a diabetic neuropathy model
- 25 September 2001
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 430 (2-3) , 229-234
- https://doi.org/10.1016/s0014-2999(01)01373-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The Novel Analgesic Compound OT-7100 (5-n-Butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo [1,5-a] pyrimidine) Attenuates Mechanical Nociceptive Responses in Animal Models of Acute and Peripheral Neuropathic HyperalgesiaThe Japanese Journal of Pharmacology, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocainePain, 1996
- Gabapentin Adjunctive Therapy in Neuropathic Pain StatesThe Clinical Journal of Pain, 1996
- Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic painPain, 1993
- A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injuryPAIN®, 1990
- A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in manPain, 1988
- Lack of analgesic effect of opioids on neuropathic and idiopathic forms of painPain, 1988
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983